They also frequently have neutralizing autoantibodies against IL-17A and/or IL-17F that underlie chronic mucocutaneous candidiasis, a disease that is seen in patients with inborn errors of IL-17A/F immunity4. Here, IL17A is linked to Chronic mucocutaneous candidosis.